Coxsackievirus B3 affects endothelial tight junctions: Possible relationship to ZO-1 and F-actin, as well as p38 MAPK activity

Cell Biology International

Volumn 31, Issue 10, 2007, Pages 1207-1213

  Ju, Yuanrong ^a   Wang, Tao ^b   Li, Yang ^c   Xin, Wei ^a   Wang, Shuyun ^d   Li, Jianfeng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shandong Medical Imaging Research Institute   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Coxsackievirus; F actin; HUVEC; p38 MAPK; ZO 1

Indexed keywords

F ACTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN ZO1; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIN; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ARTICLE; COXSACKIE VIRUS B3; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; NONHUMAN; TIGHT JUNCTION; UMBILICAL VEIN; CELL CULTURE; CELL MEMBRANE PERMEABILITY; COXSACKIE VIRUS INFECTION; CYTOLOGY; DRUG ANTAGONISM; ENTEROVIRUS; METABOLISM; PATHOGENICITY; VASCULAR ENDOTHELIUM; VIROLOGY;

COXSACKIEVIRUS;

ACTINS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; ENTEROVIRUS B, HUMAN; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; MEMBRANE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PYRIDINES; TIGHT JUNCTIONS; UMBILICAL VEINS;

EID: 34447100268     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.04.003     Document Type: Article

References (28)

1. Baboonian C., Davies M.J., Booth J.C., and McKenna W.J. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 223 (1997) 31-52
2. Birukova A.A., Smurova K., Birukov K.G., Usatyuk P., Liu F., Kaibuchi K., et al. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 201 (2004) 55-70
3. Carson S.D., Hobbs J.T., Tracy S.M., and Chapman N.M. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J Virol 73 (1999) 7077-7079
4. Castillo A.M., Reyes J.L., Sanchez E., Mondragon R., and Meza I. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers. J Muscle Res Cell Motil 23 (2002) 223-234
5. Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., and Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 98 (2001) 15191-15196
6. Coyne C.B., and Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 (2006) 119-131
7. Fanning A.S., Jameson B.J., Jesaitis L.A., and Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273 (1998) 29745-29753
8. Fischbarg J., Diecke F.P., Iserovich P., and Rubashkin A. The role of the tight junction in paracellular fluid transport across corneal endothelium. Electro-osmosis as a driving force. J Membr Biol 210 (2006) 117-130
9. Grisendi S., Arpin M., and Crepaldi T. Effect of hepatocyte growth factor on assembly of zonula occludens-1 protein at the plasma membrane. J Cell Physiol 176 (1998) 465-471
10. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., and Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 280 (2001) H1241-H1248
11. Kiely B., Feldman G., and Ryan M.P. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int 63 (2003) 908-916
12. Kiemer A.K., Weber N.C., Furst R., Bildner N., Kulhanek-Heinze S., and Vollmar A.M. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 90 (2002) 874-881
13. Lum H., and Malik A.B. Mechanisms of increased endothelial permeability. Can J Physiol Pharmacol 74 (1996) 787-800
14. Madara J.L. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60 (1998) 143-159
15. Mark K.S., and Davis T.P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282 (2002) H1485-H1494
16. Mark K.S., Trickler W.J., and Miller D.W. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 297 (2001) 1051-1058
17. Martin T.A., Watkins G., Mansel R.E., and Jiang W.G. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 40 (2004) 2717-2725
18. Morigi M., Buelli S., Zanchi C., Longaretti L., Macconi D., Benigni A., et al. Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169 (2006) 1965-1975
19. Nitz T., Eisenblatter T., Psathaki K., and Galla H.J. Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Res 981 (2003) 30-40
20. Obata T., Brown G.E., and Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 28 (2000) N67-N77
21. Ohtake K., Maeno T., Ueda H., Ogihara M., Natsum E.H., and Morimoto Y. Poly-l-arginine enhances paracellular permeability via serine/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium. Pharm Res 20 (2003) 1838-1845
22. Pallansch M.A. Coxsackievirus B epidemiology and public health concerns. Curr Top Microbiol Immunol 223 (1997) 13-30
23. Romero I.A., Radewicz K., Jubin E., Michel C.C., Greenwood J., Couraud P.O., et al. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344 (2003) 112-116
24. Saijets S., Ylipaasto P., Vaarala O., Hovi T., and Roivainen M. Enterovirus infection and activation of human umbilical vein endothelial cells. J Med Virol 70 (2003) 430-439
25. Tinsley J.H., De Lanerolle P., Wilson E., Ma W., and Yuan S.Y. Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. Am J Physiol Cell Physiol 279 (2000) C1285-C1289
26. Tracy S., Chapman N.M., McManus B.M., Pallansch M.A., Beck M.A., and Carstens J. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22 (1990) 403-414
27. van Hinsbergh W.M. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscler Thromb Vasc Biol 17 (1997) 1018-1023
28. Yan W., Tiruppathi C., Qiao R., Lum H., and Malik A.B. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol 166 (1996) 561-567